Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of Alzheimer's disease

Frontiers in Pharmacology

Volumn 7, Issue AUG, 2016, Pages

  Liu, Zun Jing ^a   Li, Zhong Hao ^a   Liu, Lei ^a   Tang, Wen Xiong ^a   Wang, Yu ^a   Dong, Ming Rui ^a   Xiao, Cheng ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Alzheimer's disease; Curcumin; Neuroinflammation; NF B; Peroxisome proliferator activated receptor gamma

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; AMYLOID BETA PROTEIN; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CELL FUNCTION; CHROMATIN IMMUNOPRECIPITATION; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENE EXPRESSION; GENE SILENCING; GLIA CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MEMORY CONSOLIDATION; MEMORY DISORDER; MICROGLIA; MORRIS WATER MAZE TEST; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN TARGETING; RAT; RNA INTERFERENCE; SPATIAL LEARNING; SPATIAL MEMORY; TREATMENT RESPONSE;

EID: 84988700652     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00261     Document Type: Article

References (41)

1. Agostinho, P., Cunha, R. A., and Oliveira, C. (2010). Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr. Pharm. Des. 16, 2766-2778. doi: 10.2174/138161210793176572
2. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., et al. (2000). Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421. doi: 10.1016/S0197-4580(00)00124-X
3. Amor, S., Puentes, F., Baker, D., and van der Valk, P. (2010). Inflammation in neurodegenerative diseases. Immunology 129, 154-169. doi: 10.1111/j.1365-2567.2009.03225.x
4. Angelopoulos, P., Agouridaki, H., Vaiopoulos, H., Siskou, E., Doutsou, K., Costa, V., et al. (2008). Cytokines in Alzheimer's disease and vascular dementia. Int. J. Neurosci. 118, 1659-1672. doi: 10.1080/00207450701392068
5. Baum, L., Lam, C. W., Cheung, S. K., Kwok, T., Lui, V., Tsoh, J., et al. (2008). Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol. 28, 110-113. doi: 10.1097/jcp.0b013e318160862c
6. Becaria, A., Bondy, S. C., and Campbell, A. (2003). Aluminum and copper interact in the promotion of oxidative but not inflammatory events: implications for Alzheimer's disease. J. Alzheimers Dis. 5, 31-38.
7. Begum, A. N., Jones, M. R., Lim, G. P., Morihara, T., Kim, P., Heath, D. D., et al. (2008). Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J. Pharmacol. Exp. Ther. 326, 196-208. doi: 10.1124/jpet.108.137455
8. Bright, J. J., Kanakasabai, S., Chearwae, W., and Chakraborty, S. (2008). PPAR Regulation of Inflammatory Signaling in CNS Diseases. PPAR Res. 2008:658520. doi: 10.1155/2008/658520
9. Campbell, V. A., and Gowran, A. (2007). Alzheimer's disease; taking the edge off with cannabinoids? Br. J. Pharmacol. 152, 655-662. doi: 10.1038/sj.bjp.0707446
10. Cole, G. M., Teter, B., and Frautschy, S. A. (2007). Neuroprotective effects of curcumin. Adv. Exp. Med. Biol. 595, 197-212. doi: 10.1007/978-0-387-46401-5_8
11. Collino, M., Aragno, M., Mastrocola, R., Gallicchio, M., Rosa, A. C., Dianzani, C., et al. (2006). Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur. J. Pharmacol. 530, 70-80. doi: 10.1016/j.ejphar.2005.11.049
12. Forlenza, O. V., Diniz, B. S., Talib, L. L., Mendonca, V. A., Ojopi, E. B., Gattaz, W. F., et al. (2009). Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 28, 507-512. doi: 10.1159/000255051
13. Garrido-Gil, P., Joglar, B., Rodriguez-Perez, A. I., Guerra, M. J., and Labandeira-Garcia, J. L. (2012). Involvement of PPAR-gamma in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease. J. Neuroinflammation 9:38. doi: 10.1186/1742-2094-9-38
14. Giri, R. K., Rajagopal, V., and Kalra, V. K. (2004). Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J. Neurochem. 91, 1199-1210. doi: 10.1111/j.1471-4159.2004.02800.x
15. Griffin, W. S., Sheng, J. G., Royston, M. C., Gentleman, S. M., McKenzie, J. E., Graham, D. I., et al. (1998). Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 8, 65-72. doi: 10.1111/j.1750-3639.1998.tb00136.x
16. Hernandez-Perez, J. J., Gutierrez-Guzman, B. E., Lopez-Vazquez, M. A., and Olvera-Cortes, M. E. (2015). Supramammillary serotonin reduction alters place learning and concomitant hippocampal, septal, and supramammillar theta activity in a Morris water maze. Front. Pharmacol. 6:250. doi: 10.3389/fphar.2015.00250
17. Jahrling, J. B., Hernandez, C. M., Denner, L., and Dineley, K. T. (2014). PPARgamma recruitment to active ERK during memory consolidation is required for Alzheimer's disease-related cognitive enhancement. J. Neurosci. 34, 4054-4063. doi: 10.1523/JNEUROSCI.4024-13.2014
18. Jiang, T., Zhi, X. L., Zhang, Y. H., Pan, L. F., and Zhou, P. (2012). Inhibitory effect of curcumin on the Al(III)-induced Abeta(4)(2) aggregation and neurotoxicity in vitro. Biochim. Biophys. Acta 1822, 1207-1215. doi: 10.1016/j.bbadis.2012.04.015
19. Kitazawa, M., Yamasaki, T. R., and LaFerla, F. M. (2004). Microglia as a potential bridge between the amyloid beta-peptide and tau. Ann. N.Y. Acad. Sci. 1035, 85-103. doi: 10.1196/annals.1332.006
20. Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., and Cole, G. M. (2001). The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 8370-8377.
21. Liu, Z. J., Bao, X. Q., Jia, S. H., Hu, Y. Q., Z, Y., Zhang, Y. H., et al. (2011). Constructing the screening cell model of PPAR? and to validate whether the curcumin is the natural agonist of PPAR?. J. Apoplexy Nervous Dis. 28, 872-874.
22. Liu, Z. J., Liu, H. Q., Xiao, C., Fan, H. Z., Huang, Q., Liu, Y. H., et al. (2014). Curcumin protects neurons against oxygen-glucose deprivation/reoxygenation-induced injury through activation of peroxisome proliferator-activated receptor-gamma function. J. Neurosci. Res. 92, 1549-1559. doi: 10.1002/jnr.23438
23. Liu, Z. J., Liu, W., Liu, L., Xiao, C., Wang, Y., and Jiao, J. S. (2013). Curcumin protects neuron against cerebral ischemia-induced inflammation through improving PPAR-gamma function. Evid. Based Complement. Alternat. Med. 2013:470975. doi: 10.1155/2013/470975
24. Lu, Z., Shen, Y., Wang, T., Cui, M., Wang, Z., Zhao, H., et al. (2014). Curcumin promotes neurite outgrowth via reggie-1/flotillin-2 in cortical neurons. Neurosci. Lett. 559, 7-12. doi: 10.1016/j.neulet.2013.11.029
25. Mandrekar-Colucci, S., Karlo, J. C., and Landreth, G. E. (2012). Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J. Neurosci. 32, 10117-10128. doi: 10.1523/JNEUROSCI.5268-11.2012
26. McGeer, P. L., and McGeer, E. G. (2007). NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol. Aging 28, 639-647. doi: 10.1016/j.neurobiolaging.2006.03.013
27. Moon, D. O., Jin, C. Y., Lee, J. D., Choi, Y. H., Ahn, S. C., Lee, C. M., et al. (2006). Curcumin decreases binding of Shiga-like toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-alpha and IL-1beta: suppression of p38, JNK and NF-kappaB p65 as potential targets. Biol. Pharm. Bull. 29, 1470-1475. doi: 10.1248/bpb.29.1470
28. Morales, I., Farias, G., and Maccioni, R. B. (2010). Neuroimmunomodulation in the pathogenesis of Alzheimer's disease. Neuroimmunomodulation 17, 202-204. doi: 10.1159/000258724
29. Moreno, S., Farioli-Vecchioli, S., and Ceru, M. P. (2004). Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123, 131-145. doi: 10.1016/j.neuroscience.2003.08.064
30. Samuelsson, M., Fisher, L., and Iverfeldt, K. (2005). β-Amyloid and interleukin-1beta induce persistent NF-κB activation in rat primary glial cells. Int. J. Mol. Med. 16, 449-453. doi: 10.3892/ijmm.16.3.449
31. Singh, A., and Kumar, A. (2015). Microglial inhibitory mechanism of coenzyme Q10 against abeta (1-42) induced cognitive dysfunctions: possible behavioral, biochemical, cellular, and histopathological alterations. Front. Pharmacol. 6:268. doi: 10.3389/fphar.2015.00268
32. Sodhi, R. K., Singh, N., and Jaggi, A. S. (2011). Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease. Naunyn Schmiedebergs Arch. Pharmacol. 384, 115-124. doi: 10.1007/s00210-011-0654-6
33. Song, Y. S., Park, H. J., Kim, S. Y., Lee, S. H., Yoo, H. S., Lee, H. S., et al. (2004). Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation. Neurosci. Res. 49, 69-80. doi: 10.1016/j.neures.2004.01.010
34. Spatuzza, C., Postiglione, L., Covelli, B., Ricciardone, M., Benvenuti, C., Mondola, P., et al. (2014). Effects of berberine and red yeast on proinflammatory cytokines IL-6 and TNF-alpha in peripheral blood mononuclear cells (PBMCs) of human subjects. Front. Pharmacol. 5:230. doi: 10.3389/fphar.2014.00230
35. Sun, Q., Jia, N., Wang, W., Jin, H., Xu, J., and Hu, H. (2014). Activation of SIRT1 by curcumin blocks the neurotoxicity of amyloid-beta25-35 in rat cortical neurons. Biochem. Biophys. Res. Commun. 448, 89-94. doi: 10.1016/j.bbrc.2014.04.066
36. Szekely, C. A., Thorne, J. E., Zandi, P. P., Ek, M., Messias, E., Breitner, J. C., et al. (2004). Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 23, 159-169. doi: 10.1159/000078501
37. Tsai, Y. M., Chien, C. F., Lin, L. C., and Tsai, T. H. (2011). Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int. J. Pharm. 416, 331-338. doi: 10.1016/j.ijpharm.2011.06.030
38. Wang, Y., Yin, H., Wang, L., Shuboy, A., Lou, J., Han, B., et al. (2013). Curcumin as a potential treatment for Alzheimer's disease: a study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein. Am. J. Chinese Med. 41, 59-70. doi: 10.1142/S0192415X13500055
39. Xiong, Z., Hongmei, Z., Lu, S., and Yu, L. (2011). Curcumin mediates presenilin-1 activity to reduce beta-amyloid production in a model of Alzheimer's Disease. Pharmacol. Rep. 63, 1101-1108. doi: 10.1016/S1734-1140(11)70629-6
40. Yamanaka, M., Ishikawa, T., Griep, A., Axt, D., Kummer, M. P., and Heneka, M. T. (2012). PPARgamma/RXRalpha-induced and CD36-mediated microglial amyloid-beta phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice. J. Neurosci. 32, 17321-17331. doi: 10.1523/JNEUROSCI.1569-12.2012
41. Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., et al. (2005). Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 280, 5892-5901. doi: 10.1074/jbc.M404751200